Phio Historical Cash Flow
PHIO Stock | USD 3.52 0.03 0.85% |
Analysis of Phio Pharmaceuticals cash flow over time is an excellent tool to project Phio Pharmaceuticals Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 4.8 K or Total Cash From Financing Activities of 9.8 M as it is a great indicator of Phio Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Phio Pharmaceuticals Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Phio Pharmaceuticals Corp is a good buy for the upcoming year.
Phio |
About Phio Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Phio balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Phio's non-liquid assets can be easily converted into cash.
Phio Pharmaceuticals Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Phio Pharmaceuticals Corp to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Phio Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Total Cashflows From Investing Activities
The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.Most accounts from Phio Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Phio Pharmaceuticals Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Phio Pharmaceuticals' Change To Netincome is very stable compared to the past year. As of the 22nd of September 2024, Change To Operating Activities is likely to grow to about 1.7 M, though Change In Cash is likely to grow to (3.2 M).
Phio Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Phio Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Phio Pharmaceuticals cash flow statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (7.9M) | 7.3M | 9.8M | (12.3M) | (3.3M) | (3.2M) | |
Stock Based Compensation | 300K | 136K | 480K | 414K | 303K | 287.9K | |
Free Cash Flow | (8.7M) | (8.8M) | (11.9M) | (12.3M) | (10.8M) | (11.3M) | |
Change In Working Capital | (213K) | (327K) | 990K | (1.3M) | (536K) | (509.2K) | |
Begin Period Cash Flow | 14.9M | 7.0M | 14.3M | 24.1M | 11.8M | 10.7M | |
Other Cashflows From Financing Activities | (3K) | 8.2M | 2.1M | (28K) | (37K) | (35.2K) | |
Depreciation | 67K | 72K | 75K | 193K | 184K | 115.8K | |
Other Non Cash Items | 109K | 111K | 117K | 304K | 4K | 3.8K | |
Capital Expenditures | 5K | 72K | 19K | 51K | 121K | 4.8K | |
Total Cash From Operating Activities | (8.6M) | (8.8M) | (11.9M) | (12.1M) | (10.7M) | (11.3M) | |
Net Income | (8.9M) | (8.8M) | (13.3M) | (11.5M) | (10.8M) | (11.4M) | |
Total Cash From Financing Activities | 772K | 16.1M | 21.7M | (26K) | 7.4M | 9.8M | |
End Period Cash Flow | 7.0M | 14.3M | 24.1M | 11.8M | 8.5M | 10.8M | |
Total Cashflows From Investing Activities | (5K) | (72K) | (19K) | (51K) | (58.7K) | (61.6K) | |
Sale Purchase Of Stock | 1K | (15K) | (1.0) | (28.0) | (2K) | (1.9K) | |
Investments | (5K) | (72K) | (19K) | (51K) | (121K) | (5.3K) | |
Cash And Cash Equivalents Changes | (9.3M) | 11.3M | (7.9M) | 7.3M | 8.4M | 8.8M | |
Cash Flows Other Operating | 4.7M | (2K) | (215K) | (550K) | (495K) | (470.3K) | |
Change To Netincome | 282K | 409K | 247K | 364K | 327.6K | 542.3K | |
Change To Liabilities | (521K) | 2K | (81K) | (445K) | (400.5K) | (380.5K) | |
Change To Operating Activities | (562K) | (472K) | (246K) | 1.4M | 1.7M | 1.7M | |
Issuance Of Capital Stock | 781K | 12.1M | 19.6M | 2K | 5.1M | 7.5M |
Pair Trading with Phio Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Phio Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Phio Stock
Moving against Phio Stock
0.87 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.78 | XGN | Exagen Inc | PairCorr |
0.75 | SNY | Sanofi ADR | PairCorr |
0.7 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.63 | SERA | Sera Prognostics Downward Rally | PairCorr |
The ability to find closely correlated positions to Phio Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Phio Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Phio Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Phio Pharmaceuticals Corp to buy it.
The correlation of Phio Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Phio Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Phio Pharmaceuticals Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Phio Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Information and Resources on Investing in Phio Stock
When determining whether Phio Pharmaceuticals Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phio Pharmaceuticals Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phio Pharmaceuticals Corp Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.13) | Return On Assets (0.61) | Return On Equity (1.27) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.